🔎 Trials Near Me

Akèy › Maladi ren kwonik › Texas

Etid klinik pou Maladi ren kwonik nan Texas

25 etid pou Maladi ren kwonik ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  • Baylor Scott & White, Temple
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06906627

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  • Houston Methodist, Houston
  • Baylor Scott & White, Temple
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06906640

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #5, Arlington
  • Investigator Site #21, Dallas
  • Investigator Site #9, Dallas
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07268638

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Horizon Clinical Research Group, Cypress
  • Cardiovascular Specialists of Willowbrook, Houston
  • Texas Cardiology Associates of Houston, Kingwood
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Arlington
  • Research Site, Austin
  • Research Site, Austin
  • ak 8 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Fort Worth
  • Research Site, Houston
  • Research Site, Irving
  • ak 9 plis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 24, 2026 · NCT07624305

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Arlington Nephrology, PLLC., Arlington
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
  • ak 10 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Arlington
  • Research Site, Dallas
  • Research Site, El Paso
  • ak 13 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07753993

Pivotal Study of the Velocity™ pAVF System

  • Advanced Dallas Hospital, Dallas
  • Aqua Research, Houston
  • Humble Vascular Surgical Center, Humble
  • ak 2 plis
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07153939

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • Dallas Renal Group, Dallas
  • Dallas Renal Group, Dallas
  • Nephro Asso North Illinois Indiana, Houston
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Aug 17, 2026 · NCT06858319

SPYRAL GEMINI Pilot Study

  • Baylor Heart & Vascular Hospital, Dallas
  • UT Health East Texas, Tyler
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147

Study of BHV-1400 in IgA Nephropathy

  • Site-014, Houston
  • Site-004, Houston
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jun 23, 2026 · NCT07054684

Ferric Citrate and Chronic Kidney Disease in Children

  • Children's Medical Center, Dallas, Dallas
  • Baylor College of Medicine, Houston
  • UTH, Houston
Ap rekriteFaz 2
Laj 6 a 18 · Tout sèks · Mizajou Apr 17, 2026 · NCT04741646

Kidney Precision Medicine Project

  • University of Texas at Southwestern, Dallas
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT04334707

Sickle Cell Kidney Biorepository

  • Parkland Memorial Hospital, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Apr 13, 2026 · NCT07064174

Shingrix in Renal Transplant Recipients

  • Baylor College of Medicine, Houston
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Apr 8, 2026 · NCT04128189

Transformative Research in Diabetic Nephropathy

  • University of Texas Health Science Center at San Antonio, San Antonio
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Feb 27, 2026 · NCT02986984

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  • Saint David's HealthCare Partnership, L.P., LLP, Austin
  • A&V Doctors PLLC, El Paso
  • Houston Methodist Research Institute, Houston
  • ak 2 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06001827

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

  • Dallas Renal Group - Dallas, Dallas
  • US Renal Care - Bluebonnet, Fort Worth
  • Gamma Medical Research, McAllen
  • ak 2 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Jan 29, 2026 · NCT06933472

Phosphate Assessment in Chronic Kidney Disease Patients Study

  • University of Texas Southwestern Medical Center, Dallas
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 28, 2026 · NCT07368946

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • Baylor Heart and Vascular, Dallas
  • Houston Methodist Hopsital, Houston
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Dec 22, 2025 · NCT04671771

Diuretic Tuner Clinical Decision Support

  • University of Texas Southwestern, Dallas
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2025 · NCT04759274

Prehabilitation for Kidney Transplant Candidates

  • Houston Methodist Hospital System, Houston
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Apr 18, 2025 · NCT06886256

Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake

  • Dallas Renal Group, Dallas
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 2, 2024 · NCT06533254

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.